Interestingly, similar results on CD5 down-modulation triggered by PNA treatment were obtained in peripheral blood mononuclear cells from B-CLL patients, representing a more physiological setting than immortalized cell lines. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.